Cheng; Jin Q.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cheng; Jin Q..The latest application filed is for "compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof".

Company Profile

2.48.53

Cheng; Jin Q. - Tampa FL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof Grant 10,780,104 - Cheng , et al. Sept	2020-09-22
Methods of treating breast cancer that overexpress AKT kinase Grant 10,744,148 - Cheng , et al. A	2020-08-18
Effective treatment of ovarian cancer using triciribine and related compounds Grant 10,076,534 - Cheng September 18, 2	2018-09-18
Substrate-mimetic AKT inhibitor Grant 9,896,668 - Sebti , et al. February 20, 2	2018-02-20
Compositions Including Triciribine And Epidermal Growth Factor Receptor Inhibitor Compounds Or Salts Thereof And Methods Of Use Thereof App 20170281665 - Cheng; Jin Q. ; et al.	2017-10-05
Compositions Including Triciribine And Epidermal Growth Factor Receptor Inhibitor Compounds Or Salts Thereof And Methods Of Use Thereof App 20170216337 - CHENG; Jin Q. ; et al.	2017-08-03
Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof Grant 9,655,914 - Cheng , et al. May 23, 2	2017-05-23
Effective Treatment Of Esophageal Adenocarcinoma Using Triciribine And Related Compounds App 20170080007 - CHENG; Jin Q.	2017-03-23
Effective Treatment Of Ovarian Cancer Using Triciribine And Related Compounds App 20170042927 - CHENG; Jin Q.	2017-02-16
Substrate-mimetic Akt Inhibitor App 20160369247 - Sebti; Said M. ; et al.	2016-12-22
Effective treatment of tumors and cancer with triciribine and related compounds Grant 9,518,079 - Cheng , et al. December 13, 2	2016-12-13
Compositions including triciribine and methods of use thereof Grant 9,511,084 - Cheng , et al. December 6, 2	2016-12-06
Compositions including triciribine and taxanes and methods of use thereof Grant 9,498,492 - Cheng , et al. November 22, 2	2016-11-22
Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof Grant 9,486,492 - Cheng , et al. November 8, 2	2016-11-08
Compositions including triciribine and one or more platinum compounds and methods of use thereof Grant 9,486,470 - Cheng , et al. November 8, 2	2016-11-08
Effective treatment of esophageal adenocarcinoma using triciribine and related compounds Grant 9,457,040 - Cheng October 4, 2	2016-10-04
Substrate-mimetic Akt inhibitor Grant 9,453,049 - Sebti , et al. September 27, 2	2016-09-27
Effective treatment of ovarian cancer using triciribine and related compounds Grant 9,433,635 - Cheng September 6, 2	2016-09-06
Micro-RNA profiling in ovarian cancer Grant 9,410,956 - Cheng August 9, 2	2016-08-09
Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof App 20160206644 - Cheng; Jin Q. ; et al.	2016-07-21
Inhibitors of Akt/PKB with anti-tumor activity Grant 9,359,347 - Cheng , et al. June 7, 2	2016-06-07
Compositions Including Triciribine And Trastuzumab And Methods Of Use Thereof App 20160136273 - CHENG; Jin Q. ; et al.	2016-05-19
Compositions Including Triciribine And Bortezomib And Derivatives Thereof And Methods Of Use Thereof App 20160136228 - CHENG; Jin Q. ; et al.	2016-05-19
Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof Grant 9,265,783 - Cheng , et al. February 23, 2	2016-02-23
Compositions Including Triciribine And One Or More Platinum Compounds And Methods Of Use Thereof App 20160000818 - CHENG; Jin Q. ; et al.	2016-01-07
Effective Treatment Of Esophogeal Adenocarcinoma Using Triciribine And Related Compounds App 20150359813 - CHENG; Jin Q.	2015-12-17
Compositions including triciribine and one or more platinum compounds and methods of use thereof Grant 9,211,299 - Cheng , et al. December 15, 2	2015-12-15
Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof Grant 9,192,645 - Cheng , et al. November 24, 2	2015-11-24
Compositions including triciribine and trastuzumab and methods of use thereof Grant 9,186,403 - Cheng , et al. November 17, 2	2015-11-17
Effective Treatment Of Tumors And Cancer With Triciribine And Related Compounds App 20150320784 - CHENG; Jin Q. ; et al.	2015-11-12
Compositions Including Triciribine And Taxanes And Methods Of Use Thereof App 20150297621 - CHENG; JIN Q. ; et al.	2015-10-22
Effective treatment of esophogeal adenocarcinoma using triciribine and related compounds Grant 9,150,604 - Cheng October 6, 2	2015-10-06
Effective treatment of tumors and cancer with triciribine and related compounds Grant 9,115,162 - Cheng , et al. August 25, 2	2015-08-25
Compositions including triciribine and taxanes and methods of use thereof Grant 9,101,641 - Cheng , et al. August 11, 2	2015-08-11
Effective Treatment Of Ovarian Cancer Using Triciribine And Related Compounds App 20150209378 - CHENG; Jin Q.	2015-07-30
Compositions Including Triciribine And Methods Of Use Thereof App 20150174149 - CHENG; Jin Q. ; et al.	2015-06-25
Compositions Including Triciribine And Bortezomib And Derivatives Thereof And Methods Of Use Thereof App 20150141346 - CHENG; Jin Q. ; et al.	2015-05-21
Effective Treatment Of Esophogeal Adenocarcinoma Using Triciribine And Related Compounds App 20150141366 - CHENG; Jin Q.	2015-05-21
Compositions Including Triciribine And Epidermal Growth Factor Receptor Inhibitor Compounds Or Salts Thereof And Methods Of Use Thereof App 20150141364 - CHENG; Jin Q. ; et al.	2015-05-21
Compositions Including Triciribine And One Or More Platinum Compounds And Methods Of Use Thereof App 20150030585 - CHENG; Jin Q. ; et al.	2015-01-29
Substrate-mimetic Akt Inhibitor App 20150004698 - Sebti; Said M. ; et al.	2015-01-01
Effective treatment of ovarian cancer using triciribine and related compounds Grant 8,906,869 - Cheng December 9, 2	2014-12-09
Compositions including triciribine and methods of use thereof Grant 8,901,086 - Cheng , et al. December 2, 2	2014-12-02
Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof Grant 8,865,666 - Cheng , et al. October 21, 2	2014-10-21
Effective Treatment Of Tumors And Cancer With Triciribine And Related Compounds App 20140303110 - CHENG; Jin Q. ; et al.	2014-10-09
Compositions Including Triciribine And Taxanes And Methods Of Use Thereof App 20140303111 - CHENG; Jin Q. ; et al.	2014-10-09
Compositions Including Triciribine And Trastuzumab And Methods Of Use Thereof App 20140302011 - CHENG; Jin Q. ; et al.	2014-10-09
Akt sensitization of cancer cells Grant 8,828,451 - Sebti , et al. September 9, 2	2014-09-09
Substrate-mimetic Akt inhibitor Grant 8,822,524 - Sebti , et al. September 2, 2	2014-09-02
Effective Treatment Of Ovarian Cancer Using Triciribine And Related Compounds App 20140142057 - Cheng; Jin Q.	2014-05-22
Compositions including triciribine and taxanes and methods of use thereof Grant 8,691,779 - Cheng , et al. April 8, 2	2014-04-08
Compositions including triciribine and one or more platinum compounds and methods of use thereof Grant 8,673,868 - Cheng , et al. March 18, 2	2014-03-18
Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof Grant 8,673,867 - Cheng , et al. March 18, 2	2014-03-18
Compositions including triciribine and trastuzumab and methods of use thereof Grant 8,623,834 - Cheng , et al. January 7, 2	2014-01-07
Effective treatment of esophogeal adenocarcinoma using triciribine and related compounds Grant 8,476,241 - Cheng July 2, 2	2013-07-02
Compositions Including Triciribine And Bortezomib And Derivatives Thereof And Methods Of Use Thereof App 20130157972 - CHENG; Jin Q. ; et al.	2013-06-20
Effective treatment of tumors and cancer with triciribine and related compounds Grant 8,435,959 - Cheng , et al. May 7, 2	2013-05-07
Compositions Including Triciribine And Taxanes And Methods Of Use Thereof App 20130090304 - Cheng; Jin Q. ; et al.	2013-04-11
Compositions Including Triciribine And Trastuzumab And Methods Of Use Thereof App 20130084279 - CHENG; Jin Q. ; et al.	2013-04-04
Compositions Including Triciribine And Epidermal Growth Factor Receptor Inhibitor Compounds Or Salts Thereof And Methods Of Use Thereof App 20130085116 - CHENG; Jin Q. ; et al.	2013-04-04
Compositions Including Triciribine And Methods Of Use Thereof App 20130084280 - CHENG; Jin Q. ; et al.	2013-04-04
Compositions Including Triciribine And One Or More Platinum Compounds And Methods Of Use Thereof App 20130040909 - Cheng; Jin Q. ; et al.	2013-02-14
Inhibitors Of Akt/pkb With Anti-tumor Activity App 20130034598 - Cheng; Jin Q. ; et al.	2013-02-07
Effective Treatment Of Esophogeal Adenocarcinoma Using Triciribine And Related Compounds App 20120202765 - CHENG; Jin Q.	2012-08-09
Inhibitors of AKT/PKB with anti-tumor activity Grant 8,183,249 - Cheng , et al. May 22, 2	2012-05-22
Effective treatment of esophogeal adenocarcinoma using triciribine and related compounds Grant 8,178,502 - Cheng May 15, 2	2012-05-15
Compositions Including Triciribine And Methods Of Use Thereof App 20110223154 - Cheng; Jin Q. ; et al.	2011-09-15
Compositions Including Triciribine And Epidermal Growth Factor Receptor Inhibitor Compounds Or Salts Thereof And Methods Of Use Thereof App 20110008327 - CHENG; Jin Q. ; et al.	2011-01-13
Compositions Including Triciribine And One Or More Platinum Compounds And Methods Of Use Thereof App 20100173864 - Cheng; Jin Q. ; et al.	2010-07-08
Effective Treatment Of Esophogeal Adenocarcinoma Using Triciribine And Related Compounds App 20100113381 - CHENG; Jin Q.	2010-05-06
Compositions Including Triciribine And Trastuzumab And Methods Of Use Thereof App 20100028339 - Cheng; Jin Q. ; et al.	2010-02-04
Compositions Including Triciribine And Bortezomib And Derivatives Thereof And Methods Of Use Thereof App 20100009929 - Cheng; Jin Q. ; et al.	2010-01-14
Compositions Including Triciribine And Taxanes And Methods Of Use Thereof App 20100009928 - Cheng; Jin Q. ; et al.	2010-01-14
Substrate-mimetic Akt Inhibitor App 20100009397 - Sebti; Said M. ; et al.	2010-01-14
Effective Treatment Of Ovarian Cancer Using Triciribine And Related Compounds App 20090239818 - CHENG; Jin Q.	2009-09-24
Inhibitors Of Akt/pkb With Anti-tumor Activity App 20090028855 - Cheng; Jin Q. ; et al.	2009-01-29
Akt Sensitization Of Cancer Cells App 20080131526 - Sebti; Said M. ; et al.	2008-06-05
Effective treatment of tumors and cancer with triciribine and related compounds App 20060247188 - Cheng; Jin Q. ; et al.	2006-11-02
Combination therapies for cancer and proliferative angiopathies App 20060030536 - Yu; Hua E. ; et al.	2006-02-09

Company Registrations

NCAGE Code	45D56	CHENG JIN Q
CAGE Code	45D56	CHENG, JIN Q

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.